Why the study?
The number of patients with heart failure is expected to increase with aging in Japan, necessitating updated guidelines for diagnosis and treatment.
Population
Patients with acute and chronic heart failure in Japan
Design
Summary of updated guidelines by Japanese Circulation Society and Japanese Heart Failure Society
Authors
Loading...
Supports broader HF staging and biomarker adoption in Japan; extends international consensus for cardiologists and noncardiologists.
Summarizes the 2018 Japanese guidelines for acute and chronic heart failure to facilitate broader understanding and management by both cardiologists and noncardiologists.
Yoshihiro Aizawa (2020) conducted a review in Acute and chronic heart failure. The updated Japanese guidelines for acute and chronic heart failure emphasize the staging of heart failure (A-D) and the use of biomarkers like BNP and NT-proBNP for diagnosis and prevention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: